MOESM2 of Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36Â months

Additional file 2. Complete list of identified proteins in OR (Responders) and NOR (Non-Responders) bronchial biopsies collected after 36 months of anti-IgE treatment. Accession number NCBI, Uniprot entry, Protein name, pI and MW, Spectral Count (SpC) and Score were reported for each protein. The symbol (*) was used to indicate the smooth muscle proteins. The symbol (â ) was used to indicate the periostin. The symbol (°) was used to indicate the keratins.